0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Strengths available for Jakafi:

Jakafi 5mg
Jakafi 15mg
Jakafi 20mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about Discount-Canadian-Meds.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Jakafi:

  • Armenia
  • Aruba
  • Australia
  • Azerbaijan
  • Bahamas
  • Bangladesh
  • Belarus
  • Bermuda
  • Bolivia
  • Bosnia and Herzegovina
  • Bulgaria
  • China
  • Cook Islands
  • Cuba
  • Fiji
  • Finland
  • Germany
  • Gibraltar
  • Guadeloupe
  • Guam
  • India
  • Iran
  • Iraq
  • Ireland
  • Italy
  • Netherlands
  • New Zealand
  • Nicaragua
  • Poland
  • Qatar
  • Saudi Arabia
  • Serbia
  • Singapore
  • Trinidad and Tobago
  • Tunisia
  • United Kingdom, UK
  • United States, US
  • Vanuatu
  • Vietnam
  • Yemen
View All Countries

Latest news releases on Jakafi:

Jakafi® (ruxolitinib) Prescription Medicine

Learn about Jakafi® (ruxolitinib) – Used to treat adults with polycythemia vera who have taken hydroxyurea and it did not work well enough or they could not tolerate it, adults with certain types of myelofibrosis, and to treat adults and children 12 years of age and older with acute graft-versus-host disease who have taken corticosteroids ...

Ruxolitinib - Wikipedia

Ruxolitinib (trade names Jakafi / ˈ dʒ æ k ə f aɪ / JAK-ə-fye and Jakavi) is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow, and for polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea.

Jakafi - FDA prescribing information, side effects and uses

Jakafi is indicated for treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF in adults. Polycythemia Vera. Jakafi is indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea.

Jakafi: Uses, Dosage, Side Effects & Warnings - Drugs.com

Jakafi (ruxolitinib) works by blocking certain enzymes in the body that affect blood cell production. Jakafi is used to treat myelofibrosis or polycythemia vera, which are bone marrow disorders that that affect your body's ability to produce blood cells.

Jakafi Oral : Uses, Side Effects, Interactions, Pictures ...

Find patient medical information for Jakafi Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Jakafi Prescribing Information

Jakafi is indicated for treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF in adults. 1.2 Polycythemia Vera Jakafi is indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea.

Jakafi (Ruxolitinib): Side Effects, Interactions, Warning ...

Jakafi is indicated for treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF in adults. Polycythemia Vera. Jakafi is indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea.

Jakafi | Chemotherapy Drug Information | Chemocare.com

Jakafi™ is the trade for the generic drug ruxolitinib. In some cases, health care professionals may use the generic drug name ruxolitinib when referring to the trade name Jakafi™. Drug type: Jakafi™ is a targeted therapy.

Intervene With Jakafi

Jakafi (ruxolitinib) is an FDA-approved treatment for adults with intermediate or high-risk myelofibrosis, for adults with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea and for adult and pediatric patients 12 years and older with acute graft-versus-host disease (GVHD) who are steroid refractory.

Common Side Effects of Jakafi (Ruxolitinib) Drug Center ...

Jakafi (ruxolitinib) is a kinase inhibitor used in the treatment of intermediate or high-risk types of myelofibrosis, a potentially life-threatening blood cancer. Common side effects of Jakafi include: Our Jakafi Side Effects Drug Center provides a comprehensive view of available drug information on

Customer Service
1-866-799-3435 - Use ref# 159 | Contact Form
Copyright © 2019 Discount-Canadian-Meds.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK